Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1997-2-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0899-823X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
712-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8934235-Anti-Ulcer Agents,
pubmed-meshheading:8934235-Clostridium Infections,
pubmed-meshheading:8934235-Clostridium difficile,
pubmed-meshheading:8934235-Critical Care,
pubmed-meshheading:8934235-Cross Infection,
pubmed-meshheading:8934235-Humans,
pubmed-meshheading:8934235-Research Design,
pubmed-meshheading:8934235-Sucralfate
|
pubmed:year |
1996
|
pubmed:articleTitle |
Clostridium difficile and sucralfate.
|
pubmed:publicationType |
Letter
|